Showing results (101-110 of 3,122) with videos related to
Sort By:
Pageof 313
Anti-Cancer Agents in Medicinal Chemistry|April 23, 2015
Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for CancerJen-Yang Tang, Ruei-Nian Li, Ping-Ho Chen, et al.Anti-Cancer Agents in Medicinal Chemistry|May 14, 2015
Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysisBin Yuan, Hong Zhao, Xiaofeng Xue, et al.Anti-Cancer Agents in Medicinal Chemistry|May 3, 2020
MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 CellsMohamed A Ragheb, Marwa H Soliman, Emad M Elzayat, et al.Anti-Cancer Agents in Medicinal Chemistry|May 3, 2020
The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer CellsYang Luo, Xiaoyi Fu, Bin Han, et al.Anti-Cancer Agents in Medicinal Chemistry|June 16, 2010
Fresh platinum complexes with promising antitumor activityXiaoyong WangAnti-Cancer Agents in Medicinal Chemistry|June 16, 2010
Progresses in TCM metal-based antitumour agentsZhen-Feng Chen, Hong LiangAnti-Cancer Agents in Medicinal Chemistry|January 29, 2011
Targeting focal adhesion kinase in neuroblastomaLauren Gillory, Elizabeth A BeierleAnti-Cancer Agents in Medicinal Chemistry|January 29, 2011
Metal-based inhibitors of protein tyrosine phosphatasesLiping Lu, Miaoli ZhuAnti-Cancer Agents in Medicinal Chemistry|February 5, 2011
Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumorsStephen T Keir, Mark W Dewhirst, John P Kirkpatrick, et al.Anti-Cancer Agents in Medicinal Chemistry|February 5, 2011
PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosisKatarzyna Guzińska-Ustymowicz, Anna PryczyniczPageof 313